Plain-English translation of NCT05366153 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →REDEEM-CAD is a three-year study designed to screen cancer survivors for early signs of heart disease and help prevent it from developing. Researchers will use a combination of clinical assessments and CT imaging scans to identify which survivors are at highest risk, then provide a personalized management plan to protect their heart health. The study will compare how well this approach works in cancer survivors versus people without a cancer history.
Some cancer treatments like chemotherapy and radiation can damage the heart years after treatment ends, but doctors don't have a clear, reliable way to catch this damage early in cancer survivors. This trial aims to develop and test a specialized screening and management plan that could help prevent or delay heart disease in this vulnerable group.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic at the start of the study, then return for follow-up visits at 12, 24, and 36 months (about 3 years total). At these visits, you'll complete heart-health assessments, have your risk factors reviewed and optimized (like blood pressure and cholesterol control), and undergo a CT imaging scan of your heart. The study team will use these results to create a personalized plan to protect your heart health going forward.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
Australia
Sponsor
Baker Heart and Diabetes Institute
Collaborators
Western Health, Australia, Northern Hospital, Australia
Enrollment target
~748 participants
Started
October 2023
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
40 Years – 70 Years
Last updated on clinicaltrials.gov in December 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Tom Marwick, MBBS,PhD,MPH
Baker Heart and Diabetes Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.